BIOMAT Database Logo BIOMAT Database Logo

Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism. 2021

Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Center for Excellence in Thyroid Care, Kuma Hospital, Hyogo 650-0011, Japan.

Many previous studies including ours have reported that athyreotic patients on levothyroxine (LT4) have relatively low serum free triiodothyronine (FT3) levels, whereas patients with large goitrous diseases often have high serum FT3 levels. Here we investigated Hashimoto thyroiditis (HT) patients on LT4 to study the relationship between thyroid volume (TV) and thyroid hormone status in hypothyroid patients on LT4. We retrospectively studied 408 euthyroid HT patients treated with LT4 for hypothyroidism; divided them as per TV and compared serum levels of free thyroxine (FT4) and FT3 and the FT3/FT4 ratio in each patient group with those in euthyroid matched control group. We also evaluated the association between serum FT3 level and FT3/FT4 ratio and TV among HT patients on LT4. In patients with TV <15 mL, serum FT3 levels were significantly lower than those in controls. In patients with TV 15-80 mL, serum FT3 levels were equivalent to those in controls. In patients with TV ≥80 mL, the serum FT3 levels were significantly higher than those in controls. The serum FT3 level (r = 0.35, p < 0.01) and FT3/FT4 ratio (r = 0.42, p < 0.01) showed a positive correlation with TV. TVs in HT patients on LT4 caused differences in serum thyroid hormone balance, as increasing volume increases the serum FT3 level and FT3/FT4 ratio. Serum thyroid hormone balance in HT patients with smaller thyroids was similar to that in athyreotic patients. Mild thyrotropin suppression with LT4 is needed to achieve normal FT3 levels in such patients.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013961 Thyroid Gland A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. Thyroid,Gland, Thyroid,Glands, Thyroid,Thyroid Glands,Thyroids

Related Publications

Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
October 2019, Thyroid : official journal of the American Thyroid Association,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
The association between thyroid hormone balance and thyroid volume in patients with Hashimoto thyroiditis.
September 2019, Endocrine journal,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.
January 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.
June 2022, Journal of clinical medicine,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?
July 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone.
September 2011, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism.
October 1990, Annals of internal medicine,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism.
July 2014, Journal of research in pharmacy practice,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
The association of serum thyroid stimulating hormone and serum lipids and lipoproteins in patients with suspected hypothyroidism.
April 1994, The Central African journal of medicine,
Sawako Takahashi, and Mitsuru Ito, and Yuzuki Masaki, and Mikiko Hada, and Mizuho Minakata, and Kazuyoshi Kohsaka, and Tomohiko Nakamura, and Toshihiko Kasahara, and Takumi Kudo, and Eijun Nishihara, and Shuji Fukata, and Mitsushige Nishikawa, and Takashi Akamizu, and Akira Miyauchi
Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
July 2023, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Copied contents to your clipboard!